Weiss Ratings Reiterates “Sell (E+)” Rating for 10x Genomics (NASDAQ:TXG)
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by equities researchers at Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports. Several other brokerages have also commented on TXG. Stifel Nicolaus dropped their price target on shares of 10x Genomics from $21.00 to $18.00 and […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by equities researchers at Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports. Several other brokerages have also commented on TXG. Stifel Nicolaus dropped their price target on shares of 10x Genomics from $21.00 to $18.00 and […]
